Literature DB >> 21814186

Treating mouse models of Huntington disease.

Sara J Tallaksen-Greene, Roger L Albin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21814186      PMCID： PMC3194086          DOI： 10.1038/npp.2011.158

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  1 in total

1.  Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.

Authors:  Chi-Tso Chiu; Guangping Liu; Peter Leeds; De-Maw Chuang
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853
  1 in total
  1 in total

1.  Lithium as a disease-modifying agent for prion diseases.

Authors:  A Relaño-Ginés; S Lehmann; E Brillaud; M Belondrade; D Casanova; C Hamela; C Vincent; S Poupeau; J Sarniguet; T Alvarez; J D Arnaud; J C Maurel; C Crozet
Journal:  Transl Psychiatry       Date:  2018-08-22       Impact factor: 6.222
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.